Simulations Plus SLP 深滬

等待開盤 07-18 09:30:00 美东时间

12.79

-0.120

-0.93%

華盛通

立即下載

最高13.06
今開12.91
成交量 143.37万股
最低 12.62
昨收 12.91
總市值 2.57亿
52周最高 42.11
市盈率 ^靜 26.09
換手率 7.13%
52周最低 12.62
委比 76.49%
總股本 2011.10万
歷史最高 90.08
量比 0.69
振幅 3.41%
歷史最低 0.42
每手 1
風險率 5.67%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

鹏鼎控股：有知名机构东方港湾参与的多家机构于7月16日调研我司

证券之星消息，2025年7月17日鹏鼎控股（002938）发布公告称华泰证券、大成基金、嘉实基金、中信建投、中欧基金、泓德基金、长城基金、Point 72、Tiger Pacific Capital、海富通基金、奇盛基金、中信证券、大椿基金、东方港湾、财通资管、博时基金、华富基金、景顺长城、中信保诚、泰信基金、国寿安保、利幄基金、国信证券、国联基金、长江资管、大家资产、申万菱信...

07-17 19:01
电话会总结｜ Simulations Plus(SLP)2025财年Q3业绩电话会核心要点

编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。<blockquote>业绩回顾</blockquote>• **财务业绩**： Simulations Plus (SLP) 在2025财年第三季度实现总营收2040万美元，同比增长10%，其中包括Proficiency收购带来的240万美元贡献。软件收入增长6%，占总收入的62%；服务收入增长17%，占总收入的38%。调整后EBITDA为740万美元，占收入的37%，相比去年同期的560万美元（占收入的30%）有所提升。调整后稀释每股收益为0.45美元，高于去年同期的0.27美元。公司在本季度末持有2850万美元现金和短期投资，无债务，且现金流表现强劲。• **财务指标变化*

07-16 12:12
Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Simulations Plus Inc. reported lower than expected sales and reduced guidance due to cautious biopharma spending.

07-16 01:56
Breaking Down Simulations Plus: 4 Analysts Share Their Views

In the last three months, 4 analysts have published ratings on Simulations Plus...

07-15 20:00
海外算力PCB业绩普遍超预期原因解读及未来展望

（来源：老司机驾新车） 1、海外算力PCB板块整体表现及展望 ·二季度业绩超预期表现：近期板块内多个代表性公司发布二季度经营情况，包括沪电、生益电子、鹏鼎控股等...

07-15 18:27
Simulations Plus Reports Q3 Revenue Growth Amidst Loss

Simulations Plus ( ($SLP) ) has issued an update. On July 14, 2025, Simulations...

07-15 05:19
Simulations Plus Lowers FY2025 Adj EPS Guidance from $1.07-$1.20 to $0.93-$1.06 vs $0.32 Est; Affirms FY2025 Sales Guidance of $76.000M-$80.000M vs $82.968M Est

Simulations Plus (NASDAQ:SLP) lowers FY2025 Adj EPS guidance from $1.07-$1.20 to $0.93-$1.06 vs $0.32 analyst estimate. Affirms FY2025 sales outlook from $76.000 million-$80.000 million to $76.000 million-$80.000 million

07-15 04:09
Simulations Plus Q3 Adj. EPS $0.45, Sales $20.363M Miss $20.878M Estimate

Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.07 by 516.44 percent. This is a 136.84 percent increase over earnings of $0.19 per share from

07-15 04:08
Keybanc Maintains Overweight on Simulations Plus, Lowers Price Target to $25

Keybanc analyst Scott Schoenhaus maintains Simulations Plus (NASDAQ:SLP) with a Overweight and lowers the price target from $40 to $25.

07-14 20:40
Earnings Scheduled For July 14, 2025

Companies Reporting Before The Bell • Fastenal (NASDAQ:FAST) is likely to repor...

07-14 16:32

派息除權日	每股總股息	派息日期
2024-07-29	0.06	2024-08-05
2024-04-26	0.06	2024-05-06
2024-01-26	0.06	2024-02-05
2023-10-27	0.06	2023-11-06
2023-07-28	0.06	2023-08-07
2023-04-21	0.06	2023-05-01
2023-01-27	0.06	2023-02-06
2022-10-28	0.06	2022-11-07
2022-07-22	0.06	2022-08-01
2022-04-22	0.06	2022-05-02
2022-01-28	0.06	2022-02-07
2021-10-22	0.06	2021-11-01
2021-07-23	0.06	2021-08-02
2021-04-23	0.06	2021-05-03
2021-01-22	0.06	2021-02-01
2020-10-23	0.06	2020-11-02
2020-07-24	0.06	2020-08-03
2020-04-23	0.06	2020-05-01
2020-01-24	0.06	2020-02-03
2019-10-24	0.06	2019-11-01
2019-07-24	0.06	2019-08-01
2019-04-23	0.06	2019-05-01
2019-01-24	0.06	2019-02-01
2018-10-31	0.06	2018-11-08
2018-07-25	0.06	2018-08-02
2018-04-24	0.06	2018-05-02
2018-01-25	0.06	2018-02-02
2017-11-10	0.06	2017-11-20
2017-07-26	0.05	2017-08-04
2017-05-04	0.05	2017-05-15
2017-01-26	0.05	2017-02-06
2016-11-08	0.05	2016-11-17
2016-08-09	0.05	2016-08-18
2016-04-28	0.05	2016-05-09
2016-01-27	0.05	2016-02-05
2015-11-05	0.05	2015-11-16
2015-07-21	0.05	2015-07-30
2015-05-07	0.05	2015-05-18
2015-01-22	0.05	2015-02-02
2014-11-05	0.05	2014-11-14
2014-07-31	0.05	2014-08-11
2014-05-07	0.05	2014-05-16
2014-02-12	0.05	2014-02-24
2013-11-06	0.04	2013-11-15
2013-08-08	0.03	2013-08-15
2013-05-03	0.03	2013-05-10
2012-12-20	0.14	2012-12-28
2012-11-06	0.05	2012-11-13
2012-08-03	0.05	2012-08-10
2012-04-25	0.05	2012-05-08
2012-02-16	0.05	2012-03-01

公司名稱	Simulations Plus
行業分類	医疗保健软件
業務描述	Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

Simulations Plus SLP 深 滬

12.79

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Simulations Plus SLP 深滬